Heroin and other opioids

DrugInfo newsletter, volume 9, number 3, September 2011.

This newsletter focuses on the treatment models available for opioid misuse, and gives practical examples of some of these.

Download this newsletter in a print-friendly format [PDF: 956KB](new window)

To view this newsletter you will need Adobe Acrobat Reader. If you do not have Adobe Acrobat Reader (version 9.3), click on the link below and follow the instructions to install this free software:

Contents

Moves toward wider availability of Naloxone
Professor Simon Lenton, Deputy Director and Project Leader, National Drug Research Institute, Curtin University, Western Australia.

Guest editorial: Reforming opioid treatment in Australia
Associate Professor Nicholas Lintzeris, Director, Drug and Alcohol Services, SESLHD c/o The Langon Centre, New South Wales.

Street based heroin use in Vietnamese communities
Peter Higgs, Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, University of New South Wales, New South Wales.

Heroin and other opioids in Aboriginal peole who inject drugs in Victoria
Peter Waples-Crowe, Team Leader, Public Health & Research Unit, Victorian Aboriginal Community Controlled Health Organisation, Victoria.

The prescription drug "epidemic" in the US: What is the response?
Suzanne Nielsen, NIDA Invest CTN Fellow, UCLA Integrated Substance Abuse Programs, Los Angeles, California; Senior Research Fellow, Turning Point Alcohol & Drug Centre; and Adjunct Senior Lecturer, Eastern Health Clinical School, Monash University, Victoria.

The Pharmacotherapy, Advocacy, Mediation and Support service (PAMS) based at Harm Reduction Victoria
Sarah Lord, The PAMS Service, Organisational Services Team Leader, Harm Reduction Victoria (formerly VIVAIDS Inc.), Victoria.

The primary healthcare model—a foundation for evidence-based alcohol and other drug practice
Dr Ingrid van Beek AM, Director, Kirketon Road Centre, New South Wales.